Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

A comprehensive evaluation of survey questions for adherence to antiretroviral medications and exploratory analyses for identifying optimal sets of survey questions.

Liu H, Miller LG, Hays RD, Golin CE, Zhao H, Wenger NS, Kaplan AH.

AIDS Patient Care STDS. 2006 Nov;20(11):760-72.

PMID:
17134350
2.

Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.

Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA.

AIDS Behav. 2006 May;10(3):227-45. Review.

3.

Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors.

Liu H, Miller LG, Hays RD, Golin CE, Wu T, Wenger NS, Kaplan AH.

J Acquir Immune Defic Syndr. 2006 Mar;41(3):315-22.

PMID:
16540932
4.

Pillboxes and antiretroviral adherence: prevalence of use, perceived benefits, and implications for electronic medication monitoring devices.

Kalichman SC, Cain D, Cherry C, Kalichman M, Pope H.

AIDS Patient Care STDS. 2005 Dec;19(12):833-9.

PMID:
16375615
5.

Measuring adherence to highly active antiretroviral therapy: implications for research and practice.

Kerr T, Walsh J, Lloyd-Smith E, Wood E.

Curr HIV/AIDS Rep. 2005 Nov;2(4):200-5. Review.

PMID:
16343379
6.

Predictors for non-adherence to antiretroviral therapy.

Wilson KJ, Doxanakis A, Fairley CK.

Sex Health. 2004;1(4):251-7.

PMID:
16335755
7.

Adherence to combined Lamivudine + Zidovudine versus individual components: a community-based retrospective medicaid claims analysis.

Legorreta A, Yu A, Chernicoff H, Gilmore A, Jordan J, Rosenzweig JC.

AIDS Care. 2005 Nov;17(8):938-48.

PMID:
16176890
8.
9.

Variations in patterns of highly active antiretroviral therapy (HAART) adherence.

Levine AJ, Hinkin CH, Castellon SA, Mason KI, Lam MN, Perkins A, Robinet M, Longshore D, Newton T, Myers H, Durvasula RS, Hardy DJ.

AIDS Behav. 2005 Sep;9(3):355-62.

PMID:
16088365
10.

No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa.

Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin LL.

AIDS. 2005 Aug 12;19(12):1243-9.

PMID:
16052078
12.

Modeling sources of self-report bias in a survey of drug use epidemiology.

Johnson T, Fendrich M.

Ann Epidemiol. 2005 May;15(5):381-9.

PMID:
15840552
13.

Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations.

Bova CA, Fennie KP, Knafl GJ, Dieckhaus KD, Watrous E, Williams AB.

AIDS Behav. 2005 Mar;9(1):103-10.

PMID:
15812617
14.
15.
17.

Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System.

Deschamps AE, Graeve VD, van Wijngaerden E, De Saar V, Vandamme AM, van Vaerenbergh K, Ceunen H, Bobbaers H, Peetermans WE, de Vleeschouwer PJ, de Geest S.

AIDS Patient Care STDS. 2004 Nov;18(11):644-57.

PMID:
15633262
18.

Assessing medication adherence in adolescents with HIV when electronic monitoring is not feasible.

Wiener L, Riekert K, Ryder C, Wood LV.

AIDS Patient Care STDS. 2004 Sep;18(9):527-38.

PMID:
15630773
19.
20.

A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.

Grossberg R, Zhang Y, Gross R.

J Clin Epidemiol. 2004 Oct;57(10):1107-10.

PMID:
15528063

Supplemental Content

Support Center